Skip to main content
SpringerLink
Log in

Biopharmaceuticals, an Industrial Perspective

  • Book
  • © 1999

Overview

Editors:
  1. Gary Walsh

    1. University of Limerick, Limerick, Ireland

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Brendan Murphy

    1. Limerick Institute of Technology, Limerick, Ireland

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (20 chapters)

  1. Front Matter

    Pages N3-x
    Download chapter PDF

  2. Biopharmaceuticals, an overview

    • Gary Walsh
    Pages 1-34

  3. Abciximab: The First Platelet Glycoprotein IIb/IIIa Receptor Antagonist

    • Robert E. Jordan, Marian T. Nakada, Harlan F. Weisman
    Pages 35-71

  4. Recombinant Coagulation Factor IX (BeneFIX®)

    • John Edwards, Neil Kirby
    Pages 73-108

  5. Biopharmaceutical Drug Development: A Case History

    • Mary Ann Foote, Thomas Boone
    Pages 109-123

  6. Follitropin beta (Puregon)

    • Henk J. Out
    Pages 125-148

  7. Insulin Lispro (Humalog)

    • Ronald E. Chance, N. Bradly Glazer, Kathleen L. Wishner
    Pages 149-171

  8. Interferon beta-1b — the first long-term effective treatment of relapsing-remitting and secondary progressive multiple sclerosis (MS)

    • R. Horowski, J.-F. Kapp, M. Steinmayr, St. Stuerzebecher
    Pages 173-184

  9. Reteplase, a recombinant plasminogen activator

    • Michael Waller, Ulrich Kohnert
    Pages 185-216

  10. Stabilisation of biopharmaceutical products and finished product formulations

    • Maninder S. Hora, Bao-lu Chen
    Pages 217-248

  11. Patent Law for Biopharmaceuticals

    • R. Stephen Crespi
    Pages 249-267

  12. The development of new medicines: an overview

    • John C. Stinson
    Pages 269-287

  13. The EMEA and regulatory control of (bio)pharmaceuticals within the European Union

    • Gary Walsh
    Pages 289-310

  14. Biopharmaceutical Validation: an overview

    • Stephen Slater
    Pages 311-335

  15. Validation of Biopharmaceutical Chromatography Systems

    • K. F. Williams, C. J. A. Davis
    Pages 337-362

  16. Validation of Water for Injections (WFI) for Biopharmaceutical Manufacture

    • Paschal Baker, Wael Allan
    Pages 363-387

  17. Information retrieval and the biopharmaceutical industry: an introductory overview

    • Patricia O’Donnell
    Pages 389-404

  18. Information technology and the internet as a resource of biopharmaceutical information

    • J. P. Jenuth, D. Fieldhouse, J. C.-M. Yu
    Pages 405-419

  19. Marketing Issues for the (Bio)pharmaceutical sector

    • Scott Spinka
    Pages 421-441

  20. Viral mediated gene therapy

    • Brendan Murphy
    Pages 443-469
Back to top

Keywords

About this book

Biopharmaceuticals, an Industrial Perspective provides a unique and up-to-date insight into the biopharmaceutical industry. Largely written by industrial authors, its scope is multidisciplinary. Several chapters overview the production and medical applications of specific biopharmaceuticals. Other chapters detail additional relevant issues, including the stabilisation of biopharmaceutical products, EU biopharmaceutical regulatory affairs and biopharmaceutical patent law. A series of four chapters reviews important validation issues as applied to biopharmaceutical manufacturing. Additional issues considered include biopharmaceutical information technology as well as viral and non-viral gene therapy.
The book is of particular relevance to scientists and allied professionals already employed in the biopharmaceutical industry, or to those seeking employment within this industry. Its scope also renders it an ideal reference source for students undertaking advanced undergraduate or postgraduate courses in biotechnology, pharmaceutical science, biochemistry or medicine.

Editors and Affiliations

  • University of Limerick, Limerick, Ireland

    Gary Walsh

  • Limerick Institute of Technology, Limerick, Ireland

    Brendan Murphy

Bibliographic Information

  • Book Title: Biopharmaceuticals, an Industrial Perspective

  • Editors: Gary Walsh, Brendan Murphy

  • DOI: https://doi.org/10.1007/978-94-017-0926-2

  • Publisher: Springer Dordrecht

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media B.V. 1999

  • Hardcover ISBN: 978-0-7923-5746-9Published: 30 September 1999

  • Softcover ISBN: 978-90-481-5237-7Published: 15 December 2010

  • eBook ISBN: 978-94-017-0926-2Published: 09 March 2013

  • Edition Number: 1

  • Number of Pages: X, 514

  • Topics: Biotechnology, Pharmacy, Biochemistry, general

Publish with us

Policies and ethics

Back to top

Search

Navigation